N-Alkylated derivatives of [D-Pro10]dynorphin A-(1-11) are high affinity partial agonists at the cloned rat κ-opioid receptor

European Journal of Pharmacology

Volumn 338, Issue 2, 1997, Pages 191-197

  Soderstrom, Ken ^a   Choi, Heekyung ^a   Berman, Frederick W ^a   Aldrich, Jane V ^b   Murray, Thomas F ^c  

^a OREGON STATE UNIVERSITY   (United States)

^b UNIVERSITY OF MARYLAND SCHOOL OF PHARMACY   (United States)

^c UNIVERSITY OF GEORGIA   (United States)

Author keywords

Dynorphin; Opioid; Partial agonism

Indexed keywords

ADENYLATE CYCLASE; BESTATIN; CAPTOPRIL; DIPRENORPHINE; DYNORPHIN A DERIVATIVE; FORSKOLIN; KAPPA OPIATE RECEPTOR; NORBINALTORPHIMINE; OPIATE AGONIST; PARTIAL AGONIST; RECEPTOR SUBTYPE;

ANIMAL CELL; ARTICLE; CHO CELL; CONTROLLED STUDY; DRUG RECEPTOR BINDING; HAMSTER; NONHUMAN; PRIORITY JOURNAL; RECEPTOR AFFINITY;

EID: 0030725913     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(97)81948-6     Document Type: Article

References (25)

1. + and GTP. Proc. Natl. Acad. Sci. USA. 76:1979;5626-5630.
2. Bunzow J.R., Zhang G., Bouvier C., Saez C., Ronnekleiv O.K., Kelly M.J., Grandy D.K. Characterization and distribution of a cloned rat μ-opioid receptor. J. Neurochem. 64:1995;14-24.
3. Chavkin C., Goldstein A. A specific receptor for the opioid peptide dynorphin: Structure-activity relationships. Proc. Natl. Acad. Sci. USA. 78:1981;6543-6547.
4. 10]dynorphin A-(1-11) are highly selective for κ-opioid receptors. J. Med. Chem. 35:1992;4638-4639.
5. 50) of an enzymatic reaction. Biochem. Pharmacol. 22:1973;3099-3108.
6. 10]Dynorphin-(1-11) is a highly potent and selective ligand for κ-opioid receptors. Eur. J. Pharmacol. 106:1985;457-458.
7. 10]dynorphin A-(1-11). Br. J. Pharmacol. 95:1988;1023-1030.
8. Gmerek D.E., Dykstra L.A., Woods J.H. Kappa opioids in rhesus monkeys. III. Dependence associated with chronic administration. J. Pharmacol. Exp. Ther. 242:1987;428-436.
9. Hjorth S.A., Thirstrup K., Grandy D.K., Schwartz T.W. Analysis of selective binding epitopes for the κ-opioid receptor antagonist nor-binaltorphimine. Mol. Pharmacol. 47:1995;1089-1094.
10. Hoskin P.J., Hanks G.W. Opioid agonist-antagonist drugs in acute and chronic pain states. Drugs. 41:1991;326-344.
11. Hsia J.A., Moss J., Hewlett E.L., Vaughan M. ADP-ribosylation of adenylate cyclase by pertussis toxin. J. Biol. Chem. 259:1984;1086-1090.
12. Jasper J.R., Insel P.A. Evolving concepts of partial agonism of the β-adrenergic receptor as a paradigm. Biochem. Pharmacol. 43:1992;119-130.
13. Kawasaki A.M., Knapp R.J., Walton A., Wire W.S., Zalewska T., Yamamura H.I., Porreca F., Burks T.F., Hruby V.J. Syntheses, opioid binding affinities, and potencies of dynorphin A analogues substituted in positions 1, 6, 7, 8 and 10. Int. J. Peptide Protein Res. 42:1993;411-419.
14. Knapp R.J., Malatynska E., Collins N., Fang L., Wang J.Y., Hruby V.J., Rowske W.R., Yamamura H.I. Molecular biology and pharmacology of cloned opioid receptors. FASEB. 9:1995;516-525.
15. Konkoy C.S., Childers S.R. Dynorphin-selective inhibition of adenylyl cyclase in guinea pig cerebellum membranes. Mol. Pharmacol. 36:1989;627-633.
16. Lowry O.H., Rosebrough N.J., Farr A.L., Randall R.J. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193:1951;265-275.
17. Portoghese P.S. Bivalent ligands and the message-address concept in the design of selective opioid receptor antagonists. Trends Pharmacol. Sci. 10:1989;230-235.
18. Portoghese P.S., Lipkowski A.W., Takemori A.E. Binaltorphimine and nor-binaltorphimine, potent and selective κ-opioid receptor antagonists. Life Sci. 40:1987;1287-1292.
19. Portoghese P.S., Lin C.E., Farouz-Grant F., Takemori A.E. Structure-activity relationship of N17′-substituted norbinaltorphimine congeners. Role of the N17′ basic group in the interaction with a putative address subsite on the κ opioid receptor. J. Med. Chem. 37:1994;1495-1500.
20. Raynor K., Kong H., Chen Y., Yasuda K., Yu L., Bell G.I., Reisine T. Pharmacological characterization of the cloned κ-, δ-, and μ-opioid receptors. Mol. Pharmacol. 45:1994;330-334.
21. Salomon, Y., 1979. Adenylate cyclase assay. Adv. Cycl. Nucleotide Res. 10, 35-55.
22. Strader C.D., Candelore M.R., Hill W.S., Dixon R.A.F., Sigal I.S. A single amino acid substitution in the β-adrenergic receptor promotes partial agonist activity from antagonists. J. Biol. Chem. 264(28):1989;16470-16477.
23. Tota M.R., Schimerlik M.I. Partial agonist effects on the interaction between the atrial muscarinic receptor and the inhibitory guanine nucleotide-binding protein in a reconstituted system. Mol. Pharmacol. 37:1990;996-1004.
24. Vauquelin G., Maguire M.E. Inactivation of β-adrenergic receptors by N-ethylmalemide in S49 lymphoma cells: Agonist induction of functional heterogeneity. Mol. Pharmacol. 18:1980;362-369.
25. 2-opioid receptors in guinea pig brain and guinea pig ileum membranes. Eur. J. Pharmacol. 231:1993;251-258.